Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-26-042177
Filing Date
2026-04-13
Accepted
2026-04-13 06:01:19
Documents
15
Period of Report
2025-09-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2611367d1_8ka.htm   iXBRL 8-K/A 32415
2 EXHIBIT 23.1 tm2611367d1_ex23-1.htm EX-23.1 2215
3 EXHIBIT 99.1 tm2611367d1_ex99-1.htm EX-99.1 229641
4 EXHIBIT 99.2 tm2611367d1_ex99-2.htm EX-99.2 156090
5 EXHIBIT 99.3 tm2611367d1_ex99-3.htm EX-99.3 87819
  Complete submission text file 0001104659-26-042177.txt   744939

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grdx-20250930.xsd EX-101.SCH 3023
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE grdx-20250930_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grdx-20250930_pre.xml EX-101.PRE 22364
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2611367d1_8ka_htm.xml XML 3215
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
GridAI Technologies Corp. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37853 | Film No.: 26856334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)